A
BMY icon

Allianz’s Bristol-Myers Squibb BMY Stock Holding History

Allianz’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.47M Buy
94,851
+818
+0.9% +$47K 0.06% 188
2026
Q1 		$5.7M Sell
94,033
-9,817
-9% -$572K 0.06% 164
2025
Q4 		$5.6M Buy
103,850
+9,817
+10% +$472K 0.07% 150
2025
Q3 		$4.24M Sell
94,033
-590
-0.6% -$27.6K 0.09% 147
2025
Q2 		$4.38M Sell
94,623
-5,501
-5% -$270K 0.1% 144
2025
Q1 		$6.11M Sell
100,124
-1,163
-1% -$67.8K 0.16% 122
2024
Q4 		$5.68M Sell
101,287
-25,031
-20% -$1.4M 0.15% 121
2024
Q3 		$6.54M Buy
126,318
+24,623
+24% +$1.16M 0.18% 115
2024
Q2 		$4.22M Sell
101,695
-14,888
-13% -$666K 0.12% 127
2024
Q1 		$6.32M Buy
+116,583
New +$5.94M 0.2% 115

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allianz's BMY Position: Q2 2026 in Review

Allianz increased its Bristol-Myers Squibb (BMY) stake by 0.87% in Q2 2026, buying an estimated $47K and bringing the position to 94,851 shares worth $5.47M. The position accounts for 0.06% of the portfolio, ranked #188.

Allianz first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.54M in Q3 2024. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Allianz held 94,851 shares of Bristol-Myers Squibb worth $5.47M as of Q2 2026.
  • Allianz bought 818 Bristol-Myers Squibb shares in Q2 2026, an estimated $47K.
  • Bristol-Myers Squibb made up 0.06% of Allianz's portfolio in Q2 2026, its #188 holding.
  • Allianz first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Bristol-Myers Squibb position peaked at $6.54M in Q3 2024.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.